older people; sarcopenia; quality of life; translation; validation
Abstract :
[en] Background: the first quality of life questionnaire specific to sarcopenia, the SarQoL®, has recently been developed and validated in French. To extend the availability and utilisation of this questionnaire, its translation and validation in other languages is necessary.
Objective: the purpose of this study was therefore to translate the SarQoL® into English and validate the psychometric properties of this new version.
Design: cross-sectional.
Setting: Hertfordshire, UK.
Subjects: in total, 404 participants of the Hertfordshire Cohort Study, UK.
Methods: the translation part was articulated in five stages: (i) two initial translations from French to English; (ii) synthesis of the two translations; (iii) backward translations; (iv) expert committee to compare the backward translations with the original questionnaire and (v) pre-test. To validate the English SarQoL®, we assessed its validity (discriminative power, construct validity), reliability (internal consistency, test–retest reliability) and floor/ceiling effects.
Results: the SarQoL® questionnaire was translated without any major difficulties. Results indicated a good discriminative power (lower score of quality of life for sarcopenic subjects, P = 0.01), high internal consistency (Cronbach’s alpha of 0.88), consistent construct validity (high correlations found with domains related to mobility, usual activities, vitality, physical function and low correlations with domains related to anxiety, self-care, mental health and social problems) and excellent test–retest reliability (intraclass coefficient correlation of 0.95, 95%CI 0.92–0.97). Moreover, no floor/ceiling has been found.
Conclusions: a valid SarQoL® English questionnaire is now available and can be used with confidence to better assess the disease burden associated with sarcopenia. It could also be used as a treatment outcome indicator in research.
Disciplines :
Geriatrics Public health, health care sciences & services
Author, co-author :
Beaudart, Charlotte ; Université de Liège > Département des sciences de la santé publique > Epidémiologie clinique
Edwards, Mark
Moss, Charlotte
Reginster, Jean-Yves ; Université de Liège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Moon, Rebecca
Parsons, Camille
DEMOULIN, Christophe ; Centre Hospitalier Universitaire de Liège - CHU > Service de médecine de l'appareil locomoteur
Rizzoli, René
Biver, Emmanuel
Dennison, Elaine
Bruyère, Olivier ; Université de Liège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Cooper, Cyrus
Language :
English
Title :
English translation and validation of the SarQoL®, a quality of life questionnaire specific for sarcopenia
Lauretani F, Russo CR, Bandinelli S et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol 2003; 95: 1851-60
Rolland Y, Lauwers-Cances V, Cristini C et al. Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l'OSteoporose) Study. Am J Clin Nutr 2009; 89: 1895-900
Chang S.-F., Lin P.-L. Systematic literature review and metaanalysis of the association of sarcopenia with mortality. Worldviews Evid Based Nurs 2016. 10.1111/wvn.12147
Visser M, Goodpaster BH, Kritchevsky SB et al. Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J Gerontol A Biol Sci Med Sci 2005; 60: 324-33
Janssen I., Heymsfield SB., Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002; 50: 889-96
Rantanen T. Muscle strength, disability and mortality. Scand J Med Sci Sport 2003; 13: 3-8
Rolland Y, Czerwinski S, Abellan Van Kan G et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Heal Aging 2008; 12: 433-50
Landi F, Cruz-Jentoft AJ, Liperoti R et al. Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study. Age Ageing 2013; 42: 203-9
Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on sarcopenia in older people. Age Ageing 2010; 39: 412-23
Beaudart C, Reginster JY, Petermans J et al. Quality of life and physical components linked to sarcopenia: the SarcoPhAge study. Exp Gerontol 2015. 10.1016/j.exger. 201505.003
Cooper C, Dere W, Evans W et al. Frailty and sarcopenia: definitions and outcome parameters. Osteoporos Int 2012; 23: 1839-48
Cooper C et al. Tools in the assessment of sarcopenia. Calcif Tissue Int 2013; 93: 201-10
Beaudart C., Rizzoli R., Bruyère O., Reginster J.-Y., Biver E. Sarcopenia: burden and challenges for public health. Arch Public Health 2014; 72: 45
Crosby RD., Kolotkin R. L., Williams G. R. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol 2003; 56: 395-407
Reginster J-Y, Cooper C, Rizzoli R et al. Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia. Aging Clin Exp Res 2015; 28: 47-58
Rizzoli R, Reginster JY, Arnal JF et al. Quality of life in sarcopenia and frailty. Calcif Tissue Int 2013; 93: 101-20
Beaudart C, Biver E, Reginster J-Y et al. Development of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects: the SarQoL. Age Ageing 2015; 44: 960-6
Beaudart C, Biver E, Reginster J-Y et al. Validation of SarQoL®, a specific health-related quality of life questionnaire for sarcopenia. J. Cachexia. Sarcopenia Muscle, (2016), DOI: 10.1002/jcsm.12149
Syddall HE, Aihie Sayer A, Dennison EM et al. Cohort profile: the Hertfordshire cohort study. Int J Epidemiol 2005; 34: 1234-42
van der Pas S, Castell MV, Cooper C et al. European project on osteoarthritis: design of a six-cohort study on the personal and societal burden of osteoarthritis in an older European population. BMC Musculoskelet Disord 2013; 14: 138
Nunnally JC, B. I. Psychometric theory New York: McGrawHill Inc. (1994). at http://www.amazon.com/Psych ometric-Theory-Jum-C-Nunnally/dp/007047849X
Terwee CB, Bot SDM, de Boer MR et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007; 60: 34-42
Syddall H. E., Martin H. J., Harwood R. H., Cooper C., Aihie Sayer A. The SF-36: a simple, effective measure of mobilitydisability for epidemiological studies. J Nutr Heal Aging 2009; 13: 57-62
Rabin R., de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001; 33: 337-43